Bintrafusp alfa enhances the antitumor efficacy of anti-VEGF and VEGF receptor kinase inhibitors in preclinical solid tumor models.

被引：0
|
作者：
Yeung, Tsz-Lun [1 ]
Lazorchak, Adam [1 ]
Yu, Huakui [1 ]
Qi, Jin [1 ]
Qin, Guozhong [1 ]
Marelli, Bo [1 ]
Fu, Kai [1 ]
Lan, Yan [1 ]
机构：
[1] Serono Res & Dev Inst Inc, Billerica, MA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
443
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Patient-derived tumor tissue xenograft models and their applications in assessment of a novel anti-VEGF targeted agent
    Jin, Ketao
    Lan, Huanrong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S10 - S10
  • [42] Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy
    Frentzen, Alexa
    Yu, Yong A.
    Chen, Nanhai
    Zhang, Qian
    Weibel, Stephanie
    Raab, Viktoria
    Szalay, Aladar A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (31) : 12915 - 12920
  • [43] Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors
    El Eit, Rabab
    Itani, Abdul Rahman
    Nassar, Farah
    Rasbieh, Nagham
    Jabbour, Mark
    Santina, Ahmad
    Zaatari, Ghazi
    Mahon, Francois-Xavier
    Bazarbachi, Ali
    Nasr, Rihab
    CANCER, 2019, 125 (16) : 2818 - 2828
  • [44] CEP-11981: A potent TIE-2/Pan-VEGF-R inhibitor with broad kinase inhibitory activity exhibits significant antitumor and antiangiogenic efficacy in preclinical tumor models
    Ruggeri, Bruce A.
    Underiner, Ted
    Gingrich, Diane
    Hudkins, Robert
    Angeles, Thelma
    Albom, Mark
    Chang, Hong
    Robinson, Candy
    Hunter, Kathryn
    Dobrzanski, Pawel
    Jones-Bolin, Susan
    Aimone, Lisa
    Ator, Mark
    Herbert, Jean-Marc
    Bono, Francoise
    Schaefer, Paul
    Casellas, Pierre
    Bourie, Bernard
    Mallamo, John
    Vaught, Jeffry
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3515S - 3516S
  • [45] Anti-VEGF and integrin-linked kinase knockdown inhibit angiogenesis in vitro and suppress vascular tumor growth in vivo
    Mabeta, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Myocardial Infarction after Long-Term Treatment with a Tyrosine Kinase Inhibitor (TKI) with Anti-VEGF Receptor Activity
    Paschke, L.
    Lincke, T.
    Muehlberg, K.
    Lindner, Tom H.
    Paschke, R.
    CASE REPORTS IN ENDOCRINOLOGY, 2019, 2019
  • [47] CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
    Hassan, Saima
    Buchanan, Marguerite
    Jahan, Kaushar
    Aguilar-Mahecha, Adriana
    Gaboury, Louis
    Muller, William J.
    Alsawafi, Yaqoob
    Mourskaia, Anna A.
    Siegel, Peter M.
    Salvucci, Ombretta
    Basik, Mark
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (01) : 225 - 232
  • [48] Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans
    Mordenti, J
    Thomsen, K
    Licko, V
    Chen, H
    Meng, YG
    Ferrara, N
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 14 - 21
  • [49] VEGF-TRAP exhibits potent in vivo anti-tumor activity in acute myeloid leukemia xenograft models.
    Lal, Deepika
    Park, Jennifer A.
    Drake, Allison S.
    Hoelcle, Brandon J.
    Wang, Eunice S.
    BLOOD, 2006, 108 (11) : 562A - 563A
  • [50] TAK-659, a SYK kinase inhibitor, demonstrates preclinical antitumor activity in solid tumor models
    Sappal, Jessica J.
    Theisen, Matthew
    Xiang, Zhongmin
    Tirrell, Stephen
    Christmas, Rudy
    Yu, Jie
    Zhang, Mengkun
    Kannan, Karuppiah
    CANCER RESEARCH, 2018, 78 (13)
12345